HEMODYNAMIC, RENAL, AND HORMONAL RESPONSES TO BRAIN NATRIURETIC PEPTIDE INFUSION IN PATIENTS WITH CONGESTIVE-HEART-FAILURE

被引:393
作者
YOSHIMURA, M
YASUE, H
MORITA, E
SAKAINO, N
JOUGASAKI, M
KUROSE, M
MUKOYAMA, M
SAITO, Y
NAKAO, K
IMURA, H
机构
[1] KUMAMOTO UNIV,SCH MED,DIV CARDIOL,1-1-1 HONJO,KUMAMOTO 860,JAPAN
[2] NATL CARDIOVASC CTR,RES INST,SUITA,OSAKA 565,JAPAN
[3] KYOTO UNIV,SCH MED,DEPT MED,DIV 2,KYOTO 606,JAPAN
关键词
ATRIAL NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; CONGESTIVE HEART FAILURE; NATRIURESIS;
D O I
10.1161/01.CIR.84.4.1581
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. This study was designed to examine the hemodynamic, renal, and hormonal effects of brain natriuretic peptide (BNP) infusion in patients with congestive heart failure (CHF) and in control subjects. Methods and Results. We infused synthetic human BNP at a rate of 0.1-mu-g/kg/min. BNP infusion decreased pulmonary capillary wedge pressure (control, from 5 +/- 1 to 2 +/- 1 mm Hg, p < 0.01; CHF, from 21 +/- 3 to 14 +/- 4 mm Hg, p < 0.05) and systemic vascular resistance (control, from 1,264 +/- 75 to 934 +/- 52 dyne.sec.cm-5; CHF, from 2,485 +/- 379 to 1,771 +/- 195 dyne.sec.cm-5; p < 0.01, respectively) and increased stroke volume index (control, from 49.9 +/- 2.7 to 51.5 +/- 2.3 ml/m2, p = NS; CHF, from 25.6 +/- 3.8 to 32.0 +/- 3.9 ml/m2, p < 0.01). BNP infusion significantly increased urine volume (control, from 2.3 +/- 0.7 to 7.5 +/- 1.9 ml/min; CHF, from 0.8 +/- 0.2 to 5.3 +/- 1.0 ml/min; p < 0.01, respectively), excretion of sodium (control, from 79.2 +/- 21.6 to 332.8 +/- 70.9-mu-Eq/min; CHF, from 77.4 +/- 20.8 to 753.5 +/- 108.0-mu-Eq/min; p < 0.01, respectively), and excretion of chloride (control, from 72.5 +/- 18.4 to 256.0 +/- 43.3-mu-Eq/min; CHF, from 74.0 +/- 19.6 to 708.8 +/- 103.3-mu-Eq/min; p < 0.01, respectively). Urinary excretion of sodium and of chloride in response to BNP infusion was higher in patients with CHF than in control subjects (p < 0.01, respectively). BNP infusion increased the levels of plasma atrial natriuretic peptide (control, from 65 +/- 11 to 84 +/- 14 pg/ml; CHF, from 262 +/- 65 to 301 +/- 62 pg/ml; p < 0.05, respectively) and decreased plasma aldosterone concentrations in both groups (control, from 43.3 +/- 12.1 to 27.3 +/- 7.1 pg/ml; CHF, from 91.1 +/- 34.3 to 66.3 +/- 27.2 pg/ml; p < 0.05, respectively). Conclusions. We conclude that BNP infusion improves left ventricular function in patients with CHF by vasodilation and prominent natriuretic action.
引用
收藏
页码:1581 / 1588
页数:8
相关论文
共 50 条
[41]   PATHOLOGICAL PROTEINURIAS IN PATIENTS WITH CONGESTIVE-HEART-FAILURE [J].
KRULL, F ;
NONNASTDANIEL, B ;
DANIEL, WG ;
TOEL, U ;
EHRICH, JHH .
NIEREN-UND HOCHDRUCKKRANKHEITEN, 1993, 22 (12) :635-638
[42]   Brain natriuretic peptide in heart failure patients or risk factors to heart failure [J].
Castillo, Eglee E. G. ;
Gomez, Rusvel J. B. .
INSUFICIENCIA CARDIACA, 2008, 3 (01) :21-27
[43]   PATHOPHYSIOLOGY OF CONGESTIVE-HEART-FAILURE - ROLE OF ATRIAL-NATRIURETIC-FACTOR AND THERAPEUTIC IMPLICATIONS [J].
PERRELLA, MA ;
MARGULIES, KB ;
BURNETT, JC .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1991, 69 (10) :1576-1581
[44]   RENAL EFFECTS OF LOW-DOSE PRAZOSIN IN PATIENTS WITH CONGESTIVE-HEART-FAILURE [J].
LANG, CC ;
CHOY, AMJ ;
RAHMAN, AR ;
STRUTHERS, AD .
EUROPEAN HEART JOURNAL, 1993, 14 (09) :1245-1252
[45]   INFLUENCE OF RAMIPRIL ON RENAL-FUNCTION IN PATIENTS WITH CHRONIC CONGESTIVE-HEART-FAILURE [J].
HEINTZ, B ;
VERHO, M ;
BROCKMEIER, D ;
KIRSTEN, R ;
NELSON, K ;
MAIGATTER, S ;
LEFEVRE, G ;
KIERDORF, H ;
SIEBERTH, HG .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 18 :S174-S179
[46]   Augmented response in plasma atrial natriuretic peptide to dynamic exercise in patients with congestive heart failure [J].
Kato, M ;
Kinugawa, T ;
Omodani, H ;
Osaki, S ;
Ogino, K ;
Hisatome, I ;
Miyakoda, H ;
Fujimoto, Y .
JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1996, 60 (12) :909-916
[47]   HEMODYNAMIC AND NEUROENDOCRINE RESPONSE TO ACUTE ADMINISTRATION OF THE PHOSPHODIESTERASE INHIBITOR BM14.478 IN PATIENTS WITH CONGESTIVE-HEART-FAILURE [J].
RAUCH, B ;
ZIMMERMANN, R ;
KAPP, M ;
HAASS, M ;
VONMOLITOR, S ;
SMOLARZ, A ;
NEUMANN, FJ ;
KUBLER, W ;
DIETZ, R ;
TILLMANNS, H .
CLINICAL CARDIOLOGY, 1991, 14 (05) :386-395
[48]   Abnormal rhythmic oscillations of atrial natriuretic peptide and brain natriuretic peptide in heart failure [J].
Bentzen, H ;
Pedersen, RS ;
Pedersen, HB ;
Nyvad, O ;
Pedersen, EB .
CLINICAL SCIENCE, 2003, 104 (03) :303-312
[49]   MORPHOMETRIC ANALYSIS OF ATRIAL NATRIURETIC PEPTIDE-CONTAINING GRANULES IN ATRIOCYTES OF RATS WITH EXPERIMENTAL CONGESTIVE-HEART-FAILURE [J].
AVRAMOVITCH, N ;
HOFFMAN, A ;
WINAVER, J ;
HARAMATI, A ;
LEWINSON, D .
CELL AND TISSUE RESEARCH, 1995, 279 (03) :575-583
[50]   HEMODYNAMIC-RESPONSE TO INTRAVENOUS ENALAPRILAT IN PATIENTS WITH SEVERE CONGESTIVE-HEART-FAILURE AND MITRAL REGURGITATION [J].
VARRIALE, P ;
DAVID, W ;
CHRYSSOS, BE .
CLINICAL CARDIOLOGY, 1993, 16 (03) :235-238